DK0547064T3 - Proteaseresistent PDGF og anvendelsesfremgangsmåde - Google Patents
Proteaseresistent PDGF og anvendelsesfremgangsmådeInfo
- Publication number
- DK0547064T3 DK0547064T3 DK91913764.6T DK91913764T DK0547064T3 DK 0547064 T3 DK0547064 T3 DK 0547064T3 DK 91913764 T DK91913764 T DK 91913764T DK 0547064 T3 DK0547064 T3 DK 0547064T3
- Authority
- DK
- Denmark
- Prior art keywords
- pdgf
- polypeptides
- application
- proteins
- chain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55721990A | 1990-07-23 | 1990-07-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0547064T3 true DK0547064T3 (da) | 1995-03-20 |
Family
ID=24224518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91913764.6T DK0547064T3 (da) | 1990-07-23 | 1991-07-22 | Proteaseresistent PDGF og anvendelsesfremgangsmåde |
Country Status (10)
Country | Link |
---|---|
US (2) | US5895755A (da) |
EP (1) | EP0547064B1 (da) |
JP (1) | JP2823690B2 (da) |
AT (1) | ATE107665T1 (da) |
AU (1) | AU8294991A (da) |
CA (1) | CA2087969C (da) |
DE (1) | DE69102651T2 (da) |
DK (1) | DK0547064T3 (da) |
ES (1) | ES2055611T3 (da) |
WO (1) | WO1992001716A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030105007A1 (en) * | 1995-06-07 | 2003-06-05 | Andre Beaulieu | PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds |
PT871730E (pt) * | 1995-10-11 | 2004-11-30 | Chiron Corp | Combinacao de pdgf, kgf, igf e igfbp para cicatrizacao de ferimentos |
WO1998026080A1 (en) * | 1996-12-13 | 1998-06-18 | Chiron Corporation | Method for expression of heterologous proteins in yeast |
CN1227360C (zh) | 1998-02-05 | 2005-11-16 | 史密丝克莱恩比彻姆生物有限公司 | Mage家族肿瘤相关抗原衍生物及其编码核酸序列 |
US6811777B2 (en) * | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
WO2004070018A2 (en) * | 2003-02-04 | 2004-08-19 | Ludwig Institute For Cancer Research | Vegf-b and pdgf modulation of stem cells |
US20070110737A1 (en) * | 2003-12-29 | 2007-05-17 | Allan Mishra | Compositions and method for decreasing the appearance of skin wrinkles |
WO2005065419A2 (en) * | 2003-12-29 | 2005-07-21 | Am Biosolutions | Method of culturing cells |
US7678780B2 (en) * | 2003-12-29 | 2010-03-16 | Allan Mishra | Method of treating cancer using platelet releasate |
US7462268B2 (en) | 2004-08-20 | 2008-12-09 | Allan Mishra | Particle/cell separation device and compositions |
FR2891149B1 (fr) | 2005-09-26 | 2007-11-30 | Biodex Sarl | Composition pharmaceutique a action cicatrisante comprenant un derive de dextrane soluble et un facteur de croissance derive des plaquettes. |
WO2010042658A1 (en) | 2008-10-07 | 2010-04-15 | Bioparadox, Llc | Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities |
US20140356893A1 (en) | 2013-06-04 | 2014-12-04 | Allan Mishra | Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation |
CN105085652B (zh) | 2014-05-16 | 2021-06-22 | 中国人民解放军军事医学科学院生物工程研究所 | 血小板衍生生长因子b突变体、其制备方法及用途 |
BR112017007645B1 (pt) | 2014-10-14 | 2023-05-02 | Samuel Lynch | Composições para tratar feridas |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4801542A (en) * | 1984-10-12 | 1989-01-31 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
US4766073A (en) * | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
US5045633A (en) * | 1985-02-25 | 1991-09-03 | Zymogenetics, Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
ATE131532T1 (de) * | 1986-08-13 | 1995-12-15 | Zymogenetics Inc | Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen |
AU624789B2 (en) * | 1987-02-19 | 1992-06-25 | Amgen, Inc. | Purified platelet-derived growth factor and methods for purification thereof |
DE3834079A1 (de) * | 1988-10-06 | 1990-04-12 | Biotechnolog Forschung Gmbh | Wachstumstimulierendes pdgf-bb und dessen verwendung sowie ein verfahren zu seiner herstellung und der des monomeren |
GB9101645D0 (en) * | 1991-01-25 | 1991-03-06 | British Bio Technology | Compounds |
-
1991
- 1991-07-22 JP JP3512963A patent/JP2823690B2/ja not_active Expired - Fee Related
- 1991-07-22 ES ES91913764T patent/ES2055611T3/es not_active Expired - Lifetime
- 1991-07-22 DK DK91913764.6T patent/DK0547064T3/da active
- 1991-07-22 WO PCT/US1991/005183 patent/WO1992001716A1/en active IP Right Grant
- 1991-07-22 AT AT91913764T patent/ATE107665T1/de not_active IP Right Cessation
- 1991-07-22 CA CA002087969A patent/CA2087969C/en not_active Expired - Fee Related
- 1991-07-22 DE DE69102651T patent/DE69102651T2/de not_active Expired - Fee Related
- 1991-07-22 EP EP91913764A patent/EP0547064B1/en not_active Expired - Lifetime
- 1991-07-22 AU AU82949/91A patent/AU8294991A/en not_active Abandoned
-
1994
- 1994-09-09 US US08/303,594 patent/US5895755A/en not_active Expired - Lifetime
-
1995
- 1995-05-08 US US08/436,140 patent/US5905142A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH05508775A (ja) | 1993-12-09 |
CA2087969A1 (en) | 1992-01-24 |
ATE107665T1 (de) | 1994-07-15 |
ES2055611T3 (es) | 1994-08-16 |
US5905142A (en) | 1999-05-18 |
US5895755A (en) | 1999-04-20 |
EP0547064A1 (en) | 1993-06-23 |
EP0547064B1 (en) | 1994-06-22 |
AU8294991A (en) | 1992-02-18 |
WO1992001716A1 (en) | 1992-02-06 |
JP2823690B2 (ja) | 1998-11-11 |
DE69102651T2 (de) | 1994-10-06 |
CA2087969C (en) | 2001-10-16 |
DE69102651D1 (de) | 1994-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0547064T3 (da) | Proteaseresistent PDGF og anvendelsesfremgangsmåde | |
FI852547L (fi) | Framstaellning av faktor viii och daertill hoerande produkter. | |
NO973848D0 (no) | Fremgangsmåte til fremstilling av hemoglobinliknende protein | |
ES2169095T3 (es) | Proteinas con actividad de factor viii, procedimiento para su produccion utilizando celulas modificadas por ingenieria genetica y composiciones farmaceuticas que los contienen. | |
DE3786592T3 (de) | Transformation von Trichoderma. | |
ATE198754T1 (de) | Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung | |
HK166495A (en) | HIV-1 envelope muteins lacking hypervariable domains | |
GR80840B (en) | Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof | |
DE69939330D1 (de) | Wachstumsfaktor-homologe zvegf-3 | |
GR3024002T3 (en) | Recombinant DNA method and host cells | |
DE69130981D1 (de) | Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen | |
ES8402346A1 (es) | Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente. | |
JPS6420095A (en) | Polypeptide having anti-blood coagulating action | |
EP1702071A4 (en) | TRANSACTIVATION SYSTEM FOR MAMMALIAN CELLS | |
DE69027466T2 (de) | Achromobacter-Protease-I-Gen sowie Genprodukt | |
ES2065915T3 (es) | Procedimiento para aumentar la expresion de polipeptidos en un cultivo de celula recombinante. | |
ES2047946T3 (es) | Metodos de cultivos celulares para producir proteina c activada. | |
FI895183A0 (fi) | Foerfarande foer selektiv spjaelkning av fusionsproteiner. | |
JPS6434371A (en) | Periosteal bone forming material |